Challenges in Developing Alzheimer's Blood Tests

Haydar Celik, PhD

Published on: 23/07/2024

Explore the scientific and regulatory challenges of developing blood tests for Alzheimer's disease, from biomarker selection and assay validation to clinical performance, AI-driven risk prediction, and FDA regulatory considerations.